Loading clinical trials...
Loading clinical trials...
A Multicenter, Open-label, Safety and Proof-of-concept Study to Assess Safety, Tolerability and Efficacy of AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)
Conditions
Interventions
AR-1105-CF1
AR-1105-CF2
Locations
11
United States
Retinal Research Institute, LLC
Phoenix, Arizona, United States
Retina Vitreous Associates
Beverly Hills, California, United States
Byers Eye Institute at Stanford
Palo Alto, California, United States
Florida Eye Clinic
Altamonte Springs, Florida, United States
Center for Retina & Macular Disease
Lakeland, Florida, United States
Retina Specialty Institute
Pensacola, Florida, United States
Start Date
March 13, 2019
Primary Completion Date
May 14, 2020
Completion Date
July 9, 2020
Last Updated
February 28, 2022
NCT07449936
NCT07449923
NCT07228559
NCT05802329
NCT06781255
NCT05976139
Lead Sponsor
Aerie Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions